Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | FASN | P49327 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | DPP4 | P27487 | 2/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21919792 | 0.97 | MEN1 (0.39) | MEN1KMT2AFASNALDH1A1CYP1A2 | |
| SCHEMBL17119048 | 0.92 | ALDH1A1 (0.37) | MEN1KMT2AFASNALDH1A1CYP1A2 | |
| SCHEMBL21919794 | 0.86 | GABRA1 (0.40) | MEN1KMT2AFASNALDH1A1TSHR | |
| SCHEMBL18365177 | 0.81 | MYC (0.38) | MEN1KMT2AFASNALDH1A1CYP1A2 | |
| SCHEMBL17119050 | 0.81 | CA1 (0.36) | MEN1KMT2AFASNALDH1A1CYP1A2 | |
| SCHEMBL17119528 | 0.80 | ALDH1A1 (0.37) | MEN1KMT2AFASNALDH1A1CYP1A2 | |
| SCHEMBL14139947 | 0.79 | ALDH1A1 (0.38) | MEN1KMT2AFASNALDH1A1CYP1A2 | |
| SCHEMBL14139948 | 0.79 | ALDH1A1 (0.38) | MEN1KMT2AFASNALDH1A1CYP1A2 | |
| SCHEMBL21704885 | 0.79 | CYP1A2 (0.37) | MEN1KMT2AALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL22653046 | 0.79 | ALDH1A1 (0.36) | MEN1KMT2AALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11196006-B2 | Organic compound and organic light-emitting element | CANON KABUSHIKI KAISHA (JP) | 2021-12-07 | — | — | US | disclosed |
| US-20200111963-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2020-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11196006-B2 | Organic compound and organic light-emitting element | CRY1, CRY2, NR2E3 | MEN1 429/4885KMT2A 2383/4885FASN 2217/4885 |
| US-20200111963-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CRY1, CRY2, NR2E3 | MEN1 429/4885KMT2A 2383/4885FASN 2217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.